Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Autoimmune Disease
Researchers from Harvard University, Dana-Farber Cancer Institute provide details of new studies and findings in the area of autoimmune disease
April 11th, 2007
Researchers detail in "Survival factors from activated accessory cells and their role in triggering autoimmune diseases," new data in autoimmune disease. In this recent study, researchers in the United States conducted a study "To maintain immune homeostasis, the immune system has evolved two "opposite" mechanisms to regulate the activation or expansion of effectors including potential auto-reactive lymphocytes following an immune response. One is to support the survival of activated effectors and thereby benefit the generation of memory response." "However, an inappropriate survival of auto-reactive lymphocytes may lead to autoimmune diseases, e.g. multiple sclerosis...
Source: Immunotherapy Weekly (2007-04-11)
|
